The founder and CEO of FTSE 250 constituent Oxford Nanopore Technologies has revealed that he will step down at the end of next year after more than 20 years in the role. Gordon Sanghera, who has spearheaded the MedTech since its inception in 2005, will leave after guiding the company through milestones including a 2021 … Continue reading Oxford Nanopore founder & CEO to leave after two decades in role